These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9972842)

  • 21. Role of medial prefrontal cortex dopamine in age differences in response to amphetamine in rats: locomotor activity after intra-mPFC injections of dopaminergic ligands.
    Mathews IZ; McCormick CM
    Dev Neurobiol; 2012 Nov; 72(11):1415-21. PubMed ID: 22081646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
    Vasar E; Stephenson JD; Meldrum BS
    Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of intermittent and continuous exposure to novel environmental stimuli on the development of amphetamine-induced behavioral sensitization in mice: implications for addiction.
    Fukushiro DF; Josino FS; Saito LP; Costa JM; Zanlorenci LH; Berro LF; Fernandes-Santos L; Morgado F; Mári-Kawamoto E; Frussa-Filho R
    Drug Alcohol Depend; 2012 Jul; 124(1-2):135-41. PubMed ID: 22296920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors.
    Tieppo CA; Ferreira FS; Sassatani AS; Felicio LF; Nasello AG
    Eur J Pharmacol; 2000 Jan; 387(2):189-96. PubMed ID: 10650159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration in behavioral sensitivity to amphetamine after treatment with oxotremorine. Effect of dose and test environment.
    Gralewicz S; Lutz P; Wiaderna D; Tomas T
    Behav Brain Res; 2003 Dec; 147(1-2):163-73. PubMed ID: 14659582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible involvement of medial prefrontal cortex in amphetamine-induced sensitization of mesolimbic dopamine function.
    Banks KE; Gratton A
    Eur J Pharmacol; 1995 Aug; 282(1-3):157-67. PubMed ID: 7498271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphetamine-induced zif268 mRNA expression in the medial posterior nucleus accumbens in cholecystokinin-A receptor mutant rats.
    Shilling PD; Feifel D; Kelsoe JR
    Neurosci Lett; 2000 Mar; 281(1):17-20. PubMed ID: 10686405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single exposure to restraint stress induces behavioral and neurochemical sensitization to stimulating effects of amphetamine: involvement of NMDA receptors.
    Pacchioni AM; Gioino G; Assis A; Cancela LM
    Ann N Y Acad Sci; 2002 Jun; 965():233-46. PubMed ID: 12105099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual differences in locomotor activity and sensitization.
    Hooks MS; Jones GH; Smith AD; Neill DB; Justice JB
    Pharmacol Biochem Behav; 1991 Feb; 38(2):467-70. PubMed ID: 2057515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine.
    Cador M; Bjijou Y; Stinus L
    Neuroscience; 1995 Mar; 65(2):385-95. PubMed ID: 7777156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of nicotine induced behavioral sensitization on dopamine D1 receptor pharmacology: An in vivo and ex vivo study in the rat.
    Goutier W; O'Connor JJ; Lowry JP; McCreary AC
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):933-43. PubMed ID: 25795518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine.
    Vezina P; Stewart J
    Brain Res; 1989 Oct; 499(1):108-20. PubMed ID: 2679971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
    O'Neill MF; Dourish CT; Iversen SD
    Eur J Pharmacol; 1991 Feb; 193(2):203-8. PubMed ID: 2050197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitization of amphetamine-induced wheel running suppression in rats: dose and context factors.
    Serwatkiewicz C; Limebeer C; Eikelboom R
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):219-25. PubMed ID: 10972468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of cross-sensitization of the locomotor effects of morphine in amphetamine-treated rats.
    Vanderschuren LJ; Schoffelmeer AN; Mulder AH; De Vries TJ
    Neuropsychopharmacology; 1999 Oct; 21(4):550-9. PubMed ID: 10481839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.
    Richtand NM; Welge JA; Levant B; Logue AD; Hayes S; Pritchard LM; Geracioti TD; Coolen LM; Berger SP
    Neuropsychopharmacology; 2003 Aug; 28(8):1422-32. PubMed ID: 12700693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The purinergic P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2'4'-disulphonic acid prevents both the acute locomotor effects of amphetamine and the behavioural sensitization caused by repeated amphetamine injections in rats.
    Kittner H; Krügel U; Illes P
    Neuroscience; 2001; 102(2):241-3. PubMed ID: 11166110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat.
    Häggkvist J; Björkholm C; Steensland P; Lindholm S; Franck J; Schilström B
    Addict Biol; 2011 Jan; 16(1):20-9. PubMed ID: 20192948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reductions in binding and functions of D2 dopamine receptors in the rat ventral striatum during amphetamine sensitization.
    Chen JC; Su HJ; Huang LI; Hsieh MM
    Life Sci; 1999; 64(5):343-54. PubMed ID: 10072194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.